Efficacy of minodronic acid hydrate in patients with osteoporosis
Phase of Trial: Phase IV
Latest Information Update: 13 Mar 2018
Price : $35 *
At a glance
- Drugs Minodronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 08 Mar 2018 Status changed from recruiting to completed.
- 17 Apr 2016 Results of effect of Minodronate in patients with low bone mineral density gain (n=47) presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
- 29 Sep 2013 New trial record